Aurinia Pharmaceuticals Inc (AUPH) has risen Wednesday morning, with the stock rising 7.92% in pre-market trading to 8.86. AUPH's short-term technical score of 48 indicates that the stock has traded less bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 109 out of 146 industries, Aurinia Pharmaceuticals Inc ranks higher than 55% of stocks. Aurinia Pharmaceuticals Inc has risen 81.24% over the past month, closing at $4.15 on December 28. During this period of time, the stock fell as low as $4.15 and as high as $9.55. AUPH has an average analyst recommendation of Strong Buy. The company has an average price target of $12.56.
AUPH has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on AUPH!